Login / Signup
Miriam Heinig
ORCID
Publication Activity (10 Years)
Years Active: 2021-2023
Publications (10 Years): 3
Top Topics
Current Status
Health Insurance
Advanced Non Small Cell Lung Cancer
Phase Iii
Top Venues
BMC public health
Future oncology (London, England)
Pharmacoepidemiology and drug safety
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Miriam Heinig
,
Wiebke Schäfer
,
Ingo Langner
,
Hajo Zeeb
,
Ulrike Haug
German mammography screening program: adherence, characteristics of (non-)participants and utilization of non-screening mammography-a longitudinal analysis.
BMC public health
23 (1) (2023)
Sarina Schwarz
,
Katja A Oppelt
,
Miriam Heinig
,
Ulrike Haug
Potential of German claims data to characterize utilization of new cancer drugs: the example of crizotinib.
Future oncology (London, England)
17 (18) (2021)
Miriam Heinig
,
Malte Braitmaier
,
Ulrike Haug
Prescribing of menopausal hormone therapy in Germany: Current status and changes between 2004 and 2016.
Pharmacoepidemiology and drug safety
30 (4) (2021)